Arcus Biosciences Inc (RCUS)
Debt-to-assets ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total assets | US$ in thousands | 1,150,000 | 1,095,000 | 1,345,000 | 1,592,000 | 772,292 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $1,150,000K
= 0.00
Based on the provided data, Arcus Biosciences Inc has consistently maintained a debt-to-assets ratio of 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not used any debt to finance its assets during this period. A debt-to-assets ratio of 0.00 suggests that the company's assets are entirely funded by equity, which can be a positive sign in terms of financial stability and risk management. It shows that the company has not taken on any financial leverage to support its operations and investments, reducing the potential risks associated with debt obligations. However, it's important to consider that a very low or zero debt-to-assets ratio may also indicate missed opportunities for growth or tax benefits that come with using debt as part of the capital structure.
Peer comparison
Dec 31, 2024